NEW YORK (GenomeWeb) – Luminex today announced it has signed a distribution and supply agreement with Bio-Techne that will last through 2020.

Under the terms of the agreement, Bio-Techne will distribute Luminex instruments, including the Luminex 200, Flexmap 3D, and Magpix, in major markets worldwide. Bio-Techne will also continue to develop and commercialize immunoassays for the Luminex platform.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Cancer researcher Alan Rabson has died at 92, the New York Times reports.

As the National Guideline Clearinghouse goes dark, the ECRI Institute says it will pick up the slack.

In Genome Research this week: sequencing method examines proteins parasite uses to evade immune system, L1 insertions in cancer, and more.

The Atlantic reports on private Facebook support groups for people who receive unexpected parentage results from direct-to-consumer genetic tests.